Keros Therapeutics Inc (KROS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Sales | 14,262 | 18,168 | 211,246 | 3,042 | 388 |
| Gross Profit | 14,262 | 18,168 | 211,246 | 3,042 | 388 |
| Operating Expenses | 29,646 | 57,985 | 59,206 | 56,296 | 59,045 |
| Operating Income | -15,384 | -39,817 | 152,040 | -53,254 | -58,657 |
| Other Income | 6,680 | 6,899 | 6,454 | 7,528 | 5,701 |
| Pre-tax Income | -8,704 | -32,918 | 158,494 | -45,726 | -52,956 |
| Income Tax | -1,424 | -2,222 | 10,043 | N/A | N/A |
| Net Income Continuous | -7,280 | -30,696 | 148,451 | -46,026 | -52,956 |
| Net Income | $-7,280 | $-30,696 | $148,451 | $-46,026 | $-52,956 |
| EPS Basic Total Ops | -0.18 | -0.76 | 3.66 | -1.13 | -1.41 |
| EPS Basic Continuous Ops | -0.18 | -0.76 | 3.66 | -1.13 | -1.41 |
| EPS Diluted Total Ops | -0.18 | -0.76 | 3.62 | -1.13 | -1.41 |
| EPS Diluted Continuous Ops | -0.18 | -0.76 | 3.62 | -1.13 | -1.41 |
| EPS Diluted Before Non-Recurring Items | -0.18 | -0.76 | 3.62 | -1.14 | -1.41 |
| EBITDA(a) | $-14,989 | $-39,447 | $152,384 | $-52,922 | $-58,343 |